Literature DB >> 23806781

Inflammatory cytokine-specific alterations in retinal endothelial cell function.

Tammy L Palenski1, Christine M Sorenson, Nader Sheibani.   

Abstract

Diabetic retinopathy (DR) is recognized as a chronic low-grade inflammatory disease. Retinal microvascular cell dysfunction and loss play an important role in the pathogenesis of DR. However, the basic mechanisms underlying the development and progression of DR are poorly understood. Many recent studies indicate that increased production of inflammatory factors either systemically and/or locally, is strongly associated with vascular dysfunction during diabetes. Here we sought to determine the specific impact of different inflammatory mediators on retinal endothelial cell (EC) function. Inflammatory mediators TNF-α and IL-1β attenuated the migration and capillary morphogenesis of retinal EC. These dysfunctions were associated with an increased production of reactive oxygen species, expression of inducible nitric oxide synthase, and production of total nitrate/nitrite. Incubation of retinal EC with TNF-α and IL-1β altered VE-cadherin localization, as well as the expression of other junctional proteins. In addition, TNF-α and IL-1β also altered the production of various ECM proteins including osteopontin, collagen IV, and tenascin-C. Mechanistically, these changes were concomitant with the activation of the mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB) signaling pathways. In contrast, incubation of retinal EC with MCP-1 minimally affected their migratory, junctional, and ECM properties. Together our results indicate that the presence of inflammatory mediators in diabetes may have specific and significant impact on vascular cell function, and contribute to the pathogenesis of DR.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DR; EC; ECM; IL-1β; MCP-1; TNF-α; VEGF; diabetic retinopathy; endothelial cells; extracellular matrix; interleukin1-beta; monocyte chemoattractant protein-1; tumor necrosis-factor-alpha; vascular endothelial growth factor

Mesh:

Substances:

Year:  2013        PMID: 23806781      PMCID: PMC3764503          DOI: 10.1016/j.mvr.2013.06.007

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  56 in total

1.  Development of the human retinal vasculature: cellular relations and VEGF expression.

Authors:  J M Provis; J Leech; C M Diaz; P L Penfold; J Stone; E Keshet
Journal:  Exp Eye Res       Date:  1997-10       Impact factor: 3.467

Review 2.  Inflammation and oxidative stress in angiogenesis and vascular disease.

Authors:  Young-Woong Kim; Xiaoxia Z West; Tatiana V Byzova
Journal:  J Mol Med (Berl)       Date:  2013-02-22       Impact factor: 4.599

3.  TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway.

Authors:  Shashi Kant; Wojciech Swat; Sheng Zhang; Zhong-Yin Zhang; Benjamin G Neel; Richard A Flavell; Roger J Davis
Journal:  Genes Dev       Date:  2011-10-01       Impact factor: 11.361

4.  Fibronectin matrix turnover occurs through a caveolin-1-dependent process.

Authors:  Jane Sottile; Jennifer Chandler
Journal:  Mol Biol Cell       Date:  2004-11-24       Impact factor: 4.138

5.  Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.

Authors:  R H Amin; R N Frank; A Kennedy; D Eliott; J E Puklin; G W Abrams
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-01       Impact factor: 4.799

6.  Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes.

Authors:  Shoujian Wang; Justin L Gottlieb; Christine M Sorenson; Nader Sheibani
Journal:  Arch Ophthalmol       Date:  2009-04

7.  The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.

Authors:  T Murata; K Nakagawa; A Khalil; T Ishibashi; H Inomata; K Sueishi
Journal:  Lab Invest       Date:  1996-04       Impact factor: 5.662

8.  Critical role of TNF-α-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization.

Authors:  Peirong Lu; Longbiao Li; Gaoqin Liu; Tomohisa Baba; Yuko Ishida; Mizuho Nosaka; Toshikazu Kondo; Xueguang Zhang; Naofumi Mukaida
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-14       Impact factor: 4.799

9.  Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo.

Authors:  Yi Tan; Tomonaga Ichikawa; Jinqing Li; Qiusheng Si; Huaitao Yang; Xiangbai Chen; Curtis S Goldblatt; Colin J Meyer; Xiaokun Li; Lu Cai; Taixing Cui
Journal:  Diabetes       Date:  2011-02       Impact factor: 9.461

10.  TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations.

Authors:  Antonia M Joussen; Sven Doehmen; Minh L Le; Kan Koizumi; Sven Radetzky; Tim U Krohne; Vassiliki Poulaki; Irina Semkova; Norbert Kociok
Journal:  Mol Vis       Date:  2009-07-25       Impact factor: 2.367

View more
  21 in total

1.  A function-blocking CD47 antibody modulates extracellular vesicle-mediated intercellular signaling between breast carcinoma cells and endothelial cells.

Authors:  Sukhbir Kaur; Abdel G Elkahloun; Satya P Singh; Anush Arakelyan; David D Roberts
Journal:  J Cell Commun Signal       Date:  2017-11-29       Impact factor: 5.782

2.  Transplantation of IL-10-transfected endothelial progenitor cells improves retinal vascular repair via suppressing inflammation in diabetic rats.

Authors:  Ying Wang; Lingling Fan; Xiangda Meng; Feng Jiang; Qingzhong Chen; Zhuhong Zhang; Hua Yan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-12       Impact factor: 3.117

Review 3.  Matricellular proteins in the trabecular meshwork: review and update.

Authors:  Ayan Chatterjee; Guadalupe Villarreal; Douglas J Rhee
Journal:  J Ocul Pharmacol Ther       Date:  2014-06-05       Impact factor: 2.671

4.  Sirt1 restrains lung inflammasome activation in a murine model of sepsis.

Authors:  Rong Gao; Zhongsen Ma; Yuxin Hu; Jiao Chen; Sreerama Shetty; Jian Fu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-02-06       Impact factor: 5.464

5.  Inhibitory effects of Humulus japonicus extract against hepatic injury in a diabetic rat model.

Authors:  Tae Wook Kim; Wynn Thein; Chang Yell Shin; Uy Dong Sohn
Journal:  Food Sci Biotechnol       Date:  2021-07-06       Impact factor: 3.231

6.  LRP-1 Pathway Targeted Inhibition of Vascular Abnormalities in the Retina of Diabetic Mice.

Authors:  Ahamed Hossain; Lamiya Tauhid; Ian Davenport; Thomas Huckaba; Richard Graves; Tarun Mandal; Syed Muniruzzaman; Syed A Ahmed; Partha S Bhattacharjee
Journal:  Curr Eye Res       Date:  2016-07-21       Impact factor: 2.424

7.  Basement membrane stiffening promotes retinal endothelial activation associated with diabetes.

Authors:  Xiao Yang; Harry A Scott; Finny Monickaraj; Jun Xu; Soroush Ardekani; Carolina F Nitta; Andrea Cabrera; Paul G McGuire; Umar Mohideen; Arup Das; Kaustabh Ghosh
Journal:  FASEB J       Date:  2015-10-06       Impact factor: 5.191

Review 8.  Cytochrome P450 1B1 and Primary Congenital Glaucoma.

Authors:  Yun Zhao; Christine M Sorenson; Nader Sheibani
Journal:  J Ophthalmic Vis Res       Date:  2015 Jan-Mar

Review 9.  Current trends in the monitoring and treatment of diabetic retinopathy in young adults.

Authors:  Dorota Raczyńska; Katarzyna Zorena; Beata Urban; Dominik Zalewski; Andrzej Skorek; Grażyna Malukiewicz; Bartosz L Sikorski
Journal:  Mediators Inflamm       Date:  2014-02-13       Impact factor: 4.711

10.  Aberrant phenotype in human endothelial cells of diabetic origin: implications for saphenous vein graft failure?

Authors:  Anna C Roberts; Jai Gohil; Laura Hudson; Kyle Connolly; Philip Warburton; Rakesh Suman; Peter O'Toole; David J O'Regan; Neil A Turner; Kirsten Riches; Karen E Porter
Journal:  J Diabetes Res       Date:  2015-04-08       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.